Passing of Biosecure Act a positive development Jonathan Hunt Sep 15, 2024 Jonathan Hunt MD and CEO, Syngene International analyses that though the change in the Biosecure Act around the timeline of…
Pricing pressures and regulatory overhang affect margins of Indian pharma companies in FY2023: ICRA EP News Bureau Jan 9, 2023 Outlook for the Indian pharma industry remains stable, led by expectations of continued steady revenue growth and comfortable…
